NCT05257057 Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome Status COMPLETED Phase N/A
NCT05078866 Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04978350 Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study Status COMPLETED Phase NA
NCT04920149 Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome Status RECRUITING Phase PHASE2
NCT04909671 Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome. Status UNKNOWN Phase NA
NCT04906382 Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer Status TERMINATED Phase EARLY_PHASE1
NCT04791644 Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia Status UNKNOWN Phase N/A
NCT04711434 PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients Status RECRUITING Phase PHASE3
NCT04516083 Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation Status UNKNOWN Phase N/A
NCT04508764 Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome Status TERMINATED Phase NA
NCT04500548 Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study Status WITHDRAWN Phase PHASE1
NCT04494945 Identifying and Caring for Individuals With Inherited Cancer Syndrome Status RECRUITING Phase NA
NCT04452266 Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome Status COMPLETED Phase N/A
NCT04407611 Scalable Communication Modalities for Returning Genetic Research Results Status COMPLETED Phase NA